Trevena, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Pipeline
    • Overview
    • TRV045
    • TRV250
    • TRV734
  • Products
    • OLINVYKâ„¢ (oliceridine) injection
  • Medical Affairs
    • Investigator-Initiated Trials
    • Contact Medical Information
  • Publications
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financial Info
    • Stock Info
    • Resources
    • Governance
  • Careers
  • Contact
    • Contact Medical Information
    • Whistleblower Hotline

Press Releases

Investors

Investors

  • Overview
  • Press Releases
  • Events & Presentations
    • Presentations
    • IR Calendar
  • Financial Info
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Stock Info
    • Quote
    • Analyst Coverage
    • IRS Form 8937
  • Resources
    • Email Alerts
    • Contacts
    • FAQ
  • Governance
    • Overview
    • Management Team
    • Board of Directors
    • Governance Documents

Trevena Initiates Targeted Proof-of-Concept Study to Evaluate TRV045 as a Potential Treatment for Epilepsy and Other CNS Disorders

Mar 07, 2023 7:00am EST

Trevena Announces Publication of OLINVYK Respiratory Physiology Study In ANESTHESIOLOGY

Feb 14, 2023 8:00am EST

Trevena Enrolls First Subject in TRV045 Proof-of-Concept Trial Evaluating S1PR Mechanism of Action and Target Engagement

Jan 09, 2023 7:00am EST

Trevena Regains Compliance with Nasdaq Listing Requirements

Nov 29, 2022 7:00am EST

Trevena, Inc. Announces $8.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Nov 16, 2022 8:00am EST

Trevena Announces Reverse Stock Split

Nov 09, 2022 4:01pm EST

Trevena Announces Completion of Phase 1 Study for TRV045, Novel S1P Receptor Modulator

Nov 09, 2022 7:02am EST

Trevena Reports Third Quarter 2022 Results and Provides Business Update

Nov 09, 2022 7:00am EST

Trevena to Release Third Quarter 2022 Financial Results on November 9, 2022

Nov 07, 2022 7:00am EST

Trevena Announces OLINVYK Poster Presentation at the ANESTHESIOLOGY® 2022 Annual Meeting

Oct 24, 2022 7:00am EDT
RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...31
Next
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
© 2023 Trevena, Inc. All Rights Reserved.
Privacy Policy Terms of Use Disclaimer Sitemap